MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,109 | -92.9% | 267,015 | -81.5% | 0.00% | -100.0% |
| Q2 2023 | $4,750,082 | +850.0% | 1,443,794 | +1087.7% | 0.00% | – |
| Q1 2023 | $500,000 | +21955.6% | 121,565 | -68.6% | 0.00% | – |
| Q4 2022 | $2,267 | -99.4% | 386,823 | +543.4% | 0.00% | – |
| Q3 2022 | $406,000 | -80.5% | 60,126 | -86.7% | 0.00% | – |
| Q2 2022 | $2,085,000 | +68.7% | 451,139 | +45.7% | 0.00% | – |
| Q1 2022 | $1,236,000 | +527.4% | 309,629 | +880.4% | 0.00% | – |
| Q4 2021 | $197,000 | -33.7% | 31,582 | +0.2% | 0.00% | – |
| Q3 2021 | $297,000 | -26.7% | 31,518 | +5.6% | 0.00% | – |
| Q2 2021 | $405,000 | -82.4% | 29,860 | -79.0% | 0.00% | – |
| Q1 2021 | $2,300,000 | -50.3% | 142,174 | -18.3% | 0.00% | -100.0% |
| Q4 2020 | $4,629,000 | +18.9% | 173,995 | -16.1% | 0.00% | 0.0% |
| Q3 2020 | $3,894,000 | -26.0% | 207,377 | -7.8% | 0.00% | 0.0% |
| Q2 2020 | $5,265,000 | +102.2% | 225,010 | -49.6% | 0.00% | 0.0% |
| Q1 2020 | $2,604,000 | -33.0% | 446,668 | -34.1% | 0.00% | 0.0% |
| Q4 2019 | $3,886,000 | +164.7% | 678,247 | -27.0% | 0.00% | – |
| Q3 2019 | $1,468,000 | -55.8% | 928,921 | +14.1% | 0.00% | -100.0% |
| Q2 2019 | $3,320,000 | -23.3% | 813,897 | -1.1% | 0.00% | 0.0% |
| Q1 2019 | $4,331,000 | +149.8% | 823,364 | +93.8% | 0.00% | – |
| Q4 2018 | $1,734,000 | -45.5% | 424,786 | +33.4% | 0.00% | -100.0% |
| Q3 2018 | $3,183,000 | -39.5% | 318,361 | +8.2% | 0.00% | 0.0% |
| Q2 2018 | $5,257,000 | +8.2% | 294,303 | -4.5% | 0.00% | 0.0% |
| Q1 2018 | $4,860,000 | -11.3% | 308,178 | -7.6% | 0.00% | 0.0% |
| Q4 2017 | $5,482,000 | -6.4% | 333,682 | -0.5% | 0.00% | 0.0% |
| Q3 2017 | $5,855,000 | +22.9% | 335,350 | -1.7% | 0.00% | 0.0% |
| Q2 2017 | $4,764,000 | – | 341,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |